GB2615658A - Systems and methods for transposing cargo nucleotide sequences - Google Patents

Systems and methods for transposing cargo nucleotide sequences Download PDF

Info

Publication number
GB2615658A
GB2615658A GB2304018.1A GB202304018A GB2615658A GB 2615658 A GB2615658 A GB 2615658A GB 202304018 A GB202304018 A GB 202304018A GB 2615658 A GB2615658 A GB 2615658A
Authority
GB
United Kingdom
Prior art keywords
sequence
seq
identity
complex
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB2304018.1A
Other languages
English (en)
Inventor
Thomas Brian
Brown Christopher
S A Goltsman Daniela
Butterfield Cristina
Alexander Lisa
Liu Jason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metagenomi Therapeutics Inc
Original Assignee
Metagenomi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagenomi Inc filed Critical Metagenomi Inc
Publication of GB2615658A publication Critical patent/GB2615658A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB2304018.1A 2020-08-24 2021-08-23 Systems and methods for transposing cargo nucleotide sequences Withdrawn GB2615658A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063069703P 2020-08-24 2020-08-24
US202163186698P 2021-05-10 2021-05-10
US202163232593P 2021-08-12 2021-08-12
PCT/US2021/047195 WO2022046662A1 (en) 2020-08-24 2021-08-23 Systems and methods for transposing cargo nucleotide sequences

Publications (1)

Publication Number Publication Date
GB2615658A true GB2615658A (en) 2023-08-16

Family

ID=80353933

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2304018.1A Withdrawn GB2615658A (en) 2020-08-24 2021-08-23 Systems and methods for transposing cargo nucleotide sequences

Country Status (11)

Country Link
US (1) US20240301374A1 (cg-RX-API-DMAC7.html)
EP (1) EP4200422A4 (cg-RX-API-DMAC7.html)
JP (1) JP7873002B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230054457A (cg-RX-API-DMAC7.html)
CN (1) CN116438302A (cg-RX-API-DMAC7.html)
AU (1) AU2021333586A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023003441A2 (cg-RX-API-DMAC7.html)
CA (1) CA3190758A1 (cg-RX-API-DMAC7.html)
GB (1) GB2615658A (cg-RX-API-DMAC7.html)
MX (1) MX2023002281A (cg-RX-API-DMAC7.html)
WO (1) WO2022046662A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119213129A (zh) * 2022-02-23 2024-12-27 宏基因组学公司 融合蛋白
EP4522741A2 (en) * 2022-05-09 2025-03-19 Cornell University Adaptations for high efficiency and altered pam usage with tn7-crispr-cas transposition systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017029485A1 (en) * 2015-08-14 2017-02-23 Nemesis Bioscience Ltd Delivery vehicle
WO2020131862A1 (en) * 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2728782T3 (es) * 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
WO2018152244A1 (en) * 2017-02-14 2018-08-23 Seqwell, Inc. Compositions and methods for sequencing nucleic acids
US20200255829A1 (en) * 2017-11-02 2020-08-13 Arbor Biotechnologies, Inc. Novel crispr-associated transposon systems and components
WO2020102709A1 (en) * 2018-11-16 2020-05-22 The Regents Of The University Of California Compositions and methods for delivering crispr/cas effector polypeptides
US20240301445A1 (en) * 2021-01-28 2024-09-12 Arbor Biotechnologies, Inc. Crispr-associated transposon systems and methods of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017029485A1 (en) * 2015-08-14 2017-02-23 Nemesis Bioscience Ltd Delivery vehicle
WO2020131862A1 (en) * 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NCBI, Grenbank accession no. HAX9317.1, (06/09/2018) *
PETERS, J.E. "Targeted transposition with Tn7 elements: safe sites, mobile plamsids, CRISPR/Cas and beyond", Molecular Microbiology 2019, Vol. 112 No.6, pages 1635-1644 *
PETERS, K.E. et al., "Recruitment of CRISPR-Cas system by Tn7-like transposons", PNAS 2017, VOL.114, No.35, pages E7358-E7366 *

Also Published As

Publication number Publication date
US20240301374A1 (en) 2024-09-12
EP4200422A1 (en) 2023-06-28
JP2023539237A (ja) 2023-09-13
AU2021333586A1 (en) 2023-04-27
WO2022046662A1 (en) 2022-03-03
CA3190758A1 (en) 2022-03-03
CN116438302A (zh) 2023-07-14
AU2021333586A9 (en) 2024-02-08
JP7873002B2 (ja) 2026-06-11
MX2023002281A (es) 2023-05-16
EP4200422A4 (en) 2024-08-28
KR20230054457A (ko) 2023-04-24
BR112023003441A2 (pt) 2023-05-02

Similar Documents

Publication Publication Date Title
WO2015200334A4 (en) Nuclease-mediated dna assembly
Makarova et al. The basic building blocks and evolution of CRISPR–Cas systems
Gabriel et al. Integration of retroviral vectors
US11505793B2 (en) Method for nucleic acid depletion
DE3855698D1 (de) Verfahren zur Reinigung resorbierbarer Polyester
ATE191513T1 (de) Verfahren zur amplifikation von nukleinsäuren
ATE148925T1 (de) Methode zur amplification von ziel-gerichteten segmenten von nukleinsäure durch die ineinandergeschachtelte polymerase-kettenreaktion
KR101935367B1 (ko) 이온성 액체를 사용하여 생물학적 시료로부터 핵산 증폭의 증폭 효율 및 감도를 증가시키는 방법
DK0969102T3 (da) Primere, kits og sæt af restriktionsfragmenter anvendt ved selektiv restriktionsfragmentamplifikation
Gourion et al. Avoidance of detrimental defense responses in beneficial plant–microbe interactions
ATE401424T1 (de) Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele
Nie et al. DNA cross-triggered cascading self-amplification artificial biochemical circuit
PE28795A1 (es) Procedimiento de extraccion de zinc de concentrados sulfurados
Sahajpal et al. Development and evaluation of a novel DNA purification buffer and protocol for blood samples on FTA cards
WO2024006403A3 (en) Selective histone deacetylase 8 (hdac8) degraders and methods of use thereof
JP2023539237A5 (cg-RX-API-DMAC7.html)
DE69122629D1 (de) Verfahren zur Vorbereitung von Primern für die Polymerase-Kettenreaktion und DNS-Verstärkung durch Verwendung dieser Primer
MX2023002281A (es) Sistemas y metodos para transposicion de secuencias de nucleotidos de carga.
Guo et al. Dynamic regulation of promoter-proximal RNA polymerase II pausing
Swenson Biochemical changes in the fracture hematoma
Nithya et al. Genome editing: a comparative study on the efficiency of CRISPR/Cas9 nuclease versus nickase using HIV as a model system.
Dahdah et al. Site-specific covalent attachment of DNA to proteins using a photoactivatable Tus–Ter complex
US6136865A (en) Method for reduction of the infectiousness of potentially infectious material
Yu et al. Genome editing from Cas9 to IscB: Backwards and forwards towards new breakthroughs
Jiang CRISPR-Cas9: Components and Application

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)